0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial
Sosne, Gabriel, Kleinman, Hynda K, Springs, Clark, Gross, Robert Hollis, Sung, Jihye, Kang, Shinwook
Published in International journal of molecular sciences (29.12.2022)
Published in International journal of molecular sciences (29.12.2022)
Get full text
Journal Article
Thymosin β4: potential to treat epidermolysis bullosa and other severe dermal injuries
Yang, Won S., Kang, Shinwook, Sung, Jihye, Kleinman, Hynda K.
Published in EJD. European journal of dermatology (01.10.2019)
Published in EJD. European journal of dermatology (01.10.2019)
Get full text
Journal Article
Purinergic Signaling Involvement in Thymosin β4-mediated Corneal Epithelial Cell Migration
Yang, Heung-Mo, Kang, Shin Wook, Sung, Jihye, Kim, Kyeongsoon, Kleinman, Hynda
Published in Current eye research (01.11.2020)
Published in Current eye research (01.11.2020)
Get full text
Journal Article